Literature DB >> 23090517

Peripartum cardiomyopathy: population-based birth prevalence and 7-year mortality.

Margaret A Harper1, Robert E Meyer, Cynthia J Berg.   

Abstract

OBJECTIVE: To estimate the birth prevalence and 7-year case-fatality rate of peripartum cardiomyopathy for a statewide population by applying the National Institutes of Health Workshop on Peripartum Cardiomyopathy definition, including echocardiographic criteria for left ventricular dysfunction.
METHODS: This was an epidemiologic study of residents of North Carolina experiencing an obstetric delivery or a pregnancy-related death before delivery in 2002 through 2003 including 235,599 live births. Potential cases were identified from International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM), pregnancy and cardiovascular codes followed by medical record review, and from the state pregnancy-related mortality file. Only women meeting the established definition including echocardiographic criteria for left ventricular dysfunction and women with diagnoses at autopsy were included. The state death file and the U.S. Social Security Death Index were searched for the years 2002 through 2010 for all cases.
RESULTS: A total of 740 potential cases from 70 hospitals were identified from discharge ICD-9-CM codes. The medical records for 698 (94.3%) were located and reviewed. Seventy-eight met inclusion criteria. An additional seven women had diagnoses only at autopsy. The birth prevalence was 1 case for every 2,772 live births or 3.61 cases per 10,000 live births (95% confidence interval 2.88-4.46). The 7-year case-fatality rate was 16.5% (95% confidence interval 10--25.9%). Black non-Hispanic women experienced an almost fourfold increased prevalence and fatality compared with white women. Women older than age 35 years had the highest prevalence.
CONCLUSIONS: The racial disparity in both birth prevalence and case-fatality is striking; one in six women died within 7 years. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Year:  2012        PMID: 23090517     DOI: 10.1097/aog.0b013e31826e46a1

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  22 in total

Review 1.  The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis.

Authors:  Natalie Bello; Iliana S Hurtado Rendon; Zoltan Arany
Journal:  J Am Coll Cardiol       Date:  2013-09-04       Impact factor: 24.094

2.  Clinical Outcomes for Peripartum Cardiomyopathy in North America: Results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy).

Authors:  Dennis M McNamara; Uri Elkayam; Rami Alharethi; Julie Damp; Eileen Hsich; Gregory Ewald; Kalgi Modi; Jeffrey D Alexis; Gautam V Ramani; Marc J Semigran; Jennifer Haythe; David W Markham; Josef Marek; John Gorcsan; Wen-Chi Wu; Yan Lin; Indrani Halder; Jessica Pisarcik; Leslie T Cooper; James D Fett
Journal:  J Am Coll Cardiol       Date:  2015-08-25       Impact factor: 24.094

3.  Comparison of Clinical Characteristics and Outcomes of Peripartum Cardiomyopathy Between African American and Non-African American Women.

Authors:  Olga Corazón Irizarry; Lisa D Levine; Jennifer Lewey; Theresa Boyer; Valerie Riis; Michal A Elovitz; Zolt Arany
Journal:  JAMA Cardiol       Date:  2017-11-01       Impact factor: 14.676

Review 4.  Hypertensive Disorders of Pregnancy and Heart Failure Risk.

Authors:  Sarah A Goldstein; Neha J Pagidipati
Journal:  Curr Hypertens Rep       Date:  2022-03-28       Impact factor: 4.592

5.  Epidemiology of obstetric-related ICU admissions in Maryland: 1999-2008*.

Authors:  Jonathan P Wanderer; Lisa R Leffert; Jill M Mhyre; Elena V Kuklina; William M Callaghan; Brian T Bateman
Journal:  Crit Care Med       Date:  2013-08       Impact factor: 7.598

Review 6.  Peripartum cardiomyopathy: A puzzle closer to solution.

Authors:  James D Fett
Journal:  World J Cardiol       Date:  2014-03-26

7.  Factors associated with the change in prevalence of cardiomyopathy at delivery in the period 2000-2009: a population-based prevalence study.

Authors:  C A Grotegut; E V Kuklina; K J Anstrom; R P Heine; W M Callaghan; E R Myers; A H James
Journal:  BJOG       Date:  2014-03-25       Impact factor: 6.531

8.  Peripartum Cardiomyopathy: A Review.

Authors:  Lindsay C Ballard; Adrian Cois; Bory Kea
Journal:  Curr Emerg Hosp Med Rep       Date:  2019-07-22

9.  Genetic and Phenotypic Landscape of Peripartum Cardiomyopathy.

Authors:  Rahul Goli; Jian Li; Jeff Brandimarto; Lisa D Levine; Valerie Riis; Quentin McAfee; Steven DePalma; Alireza Haghighi; J G Seidman; Christine E Seidman; Daniel Jacoby; George Macones; Daniel P Judge; Sarosh Rana; Kenneth B Margulies; Thomas P Cappola; Rami Alharethi; Julie Damp; Eileen Hsich; Uri Elkayam; Richard Sheppard; Jeffrey D Alexis; John Boehmer; Chizuko Kamiya; Finn Gustafsson; Peter Damm; Anne S Ersbøll; Sorel Goland; Denise Hilfiker-Kleiner; Dennis M McNamara; Zolt Arany
Journal:  Circulation       Date:  2021-04-20       Impact factor: 29.690

10.  Neighborhood education status drives racial disparities in clinical outcomes in PPCM.

Authors:  Kelly D Getz; Jennifer Lewey; Vicky Tam; Olga Corazon Irizarry; Lisa D Levine; Richard Aplenc; Zolt Arany
Journal:  Am Heart J       Date:  2021-04-19       Impact factor: 5.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.